Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 594G2 | — |
Vaccine preparation error; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong technique in product usage process in a patient who received Herpes zoster (Shingrix) (batch number 594G2) for prophylaxis. On 23-JUN-2025, the patient received Shingrix. On 23-JUN-2025, an unknown time after receiving Shingrix, the patient experienced wrong technique in product usage process (Verbatim: Vaccine preparation error). The action taken with Shingrix was unknown. The outcome of the wrong technique in product usage process was not applicable. Additional Information: GSK receipt date: 23-JUN-2025 HCP was the reporter. States when drawing up the final reconstituted solution of Shingrix the needle was not securely tightened to the syringe and medication leaked out of the syringe (preparation error.), which led to Wrong technique in product usage process. The patient received a dose of Shingrix using a different antigen/adjuvant of Shingrix. No further information was obtained/provided.